Candel Therapeutics logo

Candel Therapeutics share price today

(CADL)

Candel Therapeutics share price is $8.99 & ₹770.80 as on 3 Jan 2025, 2.30 'hrs' IST

$8.99

0.31

(3.57%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Candel Therapeutics share price in Dollar and Rupees. Guide to invest in Candel Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Candel Therapeutics. Get details on the Indian mutual funds that are investing in Candel Therapeutics. Get Analyst recommendations and forecasts along with all the Candel Therapeutics's financials.

Candel Therapeutics share price movements

  • Today's Low: $8.23
    Today's High: $8.99

    Day's Volatility :8.45%

  • 52 Weeks Low: $1.16
    52 Weeks High: $14.60

    52 Weeks Volatility :92.05%

Candel Therapeutics Returns

PeriodCandel Therapeutics IncIndex (Russel 2000)
3 Months
30.53%
0.0%
6 Months
49.14%
0.0%
1 Year
482.55%
0.0%
3 Years
13.91%
-21.2%

Candel Therapeutics Key Statistics

in dollars & INR

Previous Close
$8.68
Open
$8.56
Today's High
$8.99
Today's Low
$8.23
Market Capitalization
$134.3M
Today's Volume
$1.3M
52 Week High
$14.6
52 Week Low
$1.16
Revenue TTM
$31.0K
EBITDA
$-34.7M
Earnings Per Share (EPS)
$-1.73
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-480.68%

How to invest in Candel Therapeutics from India?

It is very easy for Indian residents to invest directly in Candel Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Candel Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Candel Therapeutics or CADL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Candel Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Candel Therapeutics shares which would translate to 0.095 fractional shares of Candel Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Candel Therapeutics, in just a few clicks!

Returns in Candel Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Candel Therapeutics investment value today

Current value as on today

₹6,06,331

Returns

₹5,06,331

(+506.33%)

Returns from Candel Therapeutics Stock

₹5,03,356 (+503.36%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Candel Therapeutics

17400.0%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Investment in Candel Therapeutics from India has grown in the last 30 days as on Jan 3, 2025. 17400.0% more purchase transactions for Candel Therapeutics in the last 30 days versus the previous period.

942%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Candel Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 3, 2025. 942% more investors are searching Candel Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Candel Therapeutics

  • Northpond Ventures, LLC

    5.96%

  • Vanguard Group Inc

    2.91%

  • BlackRock Inc

    2.53%

  • State Street Corp

    1.52%

  • Geode Capital Management, LLC

    1.38%

  • Sands Capital Ventures, LLC

    1.25%

Analyst Recommendation on Candel Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Candel Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Candel Therapeutics

What analysts predicted

Upside of 22.36%

Current:

$8.99

Target:

$11.00

Insights on Candel Therapeutics

  • Price Movement

    In the last 1 year, CADL stock has moved up by 498.6%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 31.0K → 1.77M (in $), with an average increase of 49.1% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -22.23M → -10.64M (in $), with an average increase of 108.9% per quarter
  • CADL vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 27.8%

Candel Therapeutics Technicals Summary

Sell

Neutral

Buy

Candel Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Candel Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Candel Therapeutics Inc
92.46%
49.14%
482.55%
13.91%
24.0%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-21.91%
15.48%
91.62%
Biontech Se
-1.42%
42.28%
6.01%
-49.15%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
22.36%
42.41%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-3.23%
81.51%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Candel Therapeutics Inc
NA
NA
NA
0.0
-4.81
-0.52
NA
0.44
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Candel Therapeutics Inc
Buy
$134.3M
24.0%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Candel Therapeutics

also known as advantagene. inc., we are a massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our gene mediated cytotoxic (gmci™) platform and our rqnestin34.5 platform. gmci™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer.
Organization
Candel Therapeutics
Employees
42
CEO
Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Industry
Miscellaneous

Management People of Candel Therapeutics

NameTitle
Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
President, CEO & Director
Dr. Francesca Barone M.D., Ph.D.
Chief Scientific Officer
Mr. Charles Schoch
Interim CFO, Principal Accounting Officer, Treasurer & Secretary
Dr. Seshu Tyagarajan Ph.D.
Chief Technical & Development Officer
Ms. Ileen B. Winick
Chief People Officer
Ms. Susan Stewart J.D., L.L.M.
Chief Regulatory Officer
Dr. William Garrett Nichols M.D., M.S.
Chief Medical Officer

Important FAQs about investing in Candel Therapeutics from India :

What is Candel Therapeutics share price today?

Candel Therapeutics share price today stands at $8.99, Open: $8.56 ; Previous Close: $8.68 ; High: $8.99 ; Low: $8.23 ; 52 Week High: $14.60 ; 52 Week Low: $1.16. The stock opens at $8.56, after a previous close of $8.68. The stock reached a daily high of $8.99 and a low of $8.23, with a 52-week high of $14.60 and a 52-week low of $1.16.

Can Indians buy Candel Therapeutics shares?

Yes, Indians can invest in the Candel Therapeutics (CADL) from India.

With INDmoney, you can buy Candel Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Candel Therapeutics at zero transaction cost.

How can I buy Candel Therapeutics shares from India?

It is very easy to buy Candel Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Candel Therapeutics be purchased?

Yes, you can buy fractional shares of Candel Therapeutics with INDmoney app.

What are the documents required to start investing in Candel Therapeutics stocks?

To start investing in Candel Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Candel Therapeutics

Today’s highest price of Candel Therapeutics (CADL) is $8.99.

Today’s lowest price of Candel Therapeutics (CADL) is $8.23.

What is today's market capitalisation of Candel Therapeutics

Today's market capitalisation of Candel Therapeutics CADL is 134.3M

What is the 52 Week High and Low Range of Candel Therapeutics

  • 52 Week High

    $14.60

  • 52 Week Low

    $1.16

What are the historical returns of Candel Therapeutics?

  • 1 Month Returns

    92.46%

  • 3 Months Returns

    49.14%

  • 1 Year Returns

    482.55%

  • 5 Years Returns

    24%

Who is the Chief Executive Officer (CEO) of Candel Therapeutics

Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. is the current Chief Executive Officer (CEO) of Candel Therapeutics.